LRRK2 G2019S通过NF-κB通路促进由寡合性α-synuclein诱导的星细胞炎症
Kai-Jie He1,2, Jin-Bao Zhang1,2, Jun-Yi Liu3
1Department of Neurology and Clinical Research Center of Neurological Disease, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China.
iScience
|October 25, 2023
概括
在帕金森病 (PD) 中,有毒的α-synuclein (O-αS) 和LRRK2突变会恶化神经炎症. 抑制LRRK2激酶活性可以降低这些炎症效应,提供一种潜在的PD治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 帕金森病 (PD) 涉及多巴胺基神经元损失和α-synuclein聚合.
- 寡合性α-synuclein (O-αS) 是一种强大的炎症调解剂.
- LRRK2突变与PD和神经炎症有遗传联系.
研究的目的:
- 为了研究O-αS和氨酸丰富的重复激酶2 (LRRK2) 在质细胞中的相互作用.
- 确定LRRK2 G2019S突变在O-αS诱导的天体细胞炎症中的作用.
- 探索LRRK2抑制在PD相关的神经炎症中的治疗潜力.
主要方法:
- 研究了O-αS和LRRK2 G2019S突变对体外和体内星球细胞的影响.
- 评估了LRRK2激酶活性抑制对神经炎症的影响.
- 研究了核因子 κB (NF-κB) 途径的参与.
主要成果:
- 这种LRRK2 G2019S突变加剧了O-αS诱导的天体细胞炎症.
- 抑制LRRK2激酶活性减轻了LRRK2 G2019S和O-αS的炎症作用.
- NF-κB途径与观察到的神经炎症反应有关.
结论:
- LRRK2激酶活性在介导PD中神经炎症方面发挥着至关重要的作用.
- 抑制LRRK2激酶活性为PD提供了一个有前途的治疗策略.
- 向LRRK2可能有助于抑制与O-αS和LRRK2突变相关的神经炎症.
相关概念视频
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Enzyme-linked Receptors
78.6K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.6K


